Postoperative Hyponatremia after Endoscopic Endonasal Resection of Pituitary Adenomas: Historical Complication Rates and Risk Factors.

Endocrine System Diseases Hyponatremia Inappropriate ADH Syndrome Pituitary Adenoma Pituitary Neoplasms Postoperative Complications

Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
18 Jul 2024
Historique:
received: 28 04 2024
revised: 11 07 2024
accepted: 12 07 2024
medline: 21 7 2024
pubmed: 21 7 2024
entrez: 20 7 2024
Statut: aheadofprint

Résumé

Hyponatremia is a common complication following endoscopic endonasal resection (EER) of pituitary adenomas. We report a single center, multi-surgeon study detailing baseline clinical data, outcomes, and factors associated with postoperative hyponatremia. A retrospective cohort study of patients undergoing EER for pituitary adenoma at Tufts Medical Center was conducted. Most procedures were performed by the senior author (CBH). Cases were included if at least one postoperative sodium value was available and pathology confirmed pituitary adenoma. Hyponatremia was considered postoperative sodium <135 mEq/L. 272 patients underwent 310 EER procedures that met study criteria. Mean age was 53.3 years and mean tumor size was 18.8 mm. Postoperative hyponatremia occurred in 12.6% of cases, with 3.6% developing hyponatremia prior to discharge. Lower pre-operative sodium was associated with increased risk of developing any postoperative hyponatremia. Older age, prolactinoma pathology, and SSRI use were associated with moderate-severe hyponatremia (≤129 mEq/L), while lower preoperative sodium was associated with mild hyponatremia (130-134 mEq/L). Hyponatremia-related readmissions within 30 days occurred in 3.9% of patients. African-American race and postoperative hyponatremia were both associated with an increased risk of 30-day readmission. Mean nadir sodium for hyponatremic patients was 129.9 mEq/L. Growth hormone secreting pathology was associated with lower postoperative nadir sodium, while higher preoperative sodium was associated with higher postoperative nadir sodium. Hyponatremia is a common postoperative complication of EER for pituitary lesions that can cause significant morbidity, increase readmissions, and lead to increased healthcare costs.

Sections du résumé

BACKGROUND BACKGROUND
Hyponatremia is a common complication following endoscopic endonasal resection (EER) of pituitary adenomas. We report a single center, multi-surgeon study detailing baseline clinical data, outcomes, and factors associated with postoperative hyponatremia.
METHODS METHODS
A retrospective cohort study of patients undergoing EER for pituitary adenoma at Tufts Medical Center was conducted. Most procedures were performed by the senior author (CBH). Cases were included if at least one postoperative sodium value was available and pathology confirmed pituitary adenoma. Hyponatremia was considered postoperative sodium <135 mEq/L.
RESULTS RESULTS
272 patients underwent 310 EER procedures that met study criteria. Mean age was 53.3 years and mean tumor size was 18.8 mm. Postoperative hyponatremia occurred in 12.6% of cases, with 3.6% developing hyponatremia prior to discharge. Lower pre-operative sodium was associated with increased risk of developing any postoperative hyponatremia. Older age, prolactinoma pathology, and SSRI use were associated with moderate-severe hyponatremia (≤129 mEq/L), while lower preoperative sodium was associated with mild hyponatremia (130-134 mEq/L). Hyponatremia-related readmissions within 30 days occurred in 3.9% of patients. African-American race and postoperative hyponatremia were both associated with an increased risk of 30-day readmission. Mean nadir sodium for hyponatremic patients was 129.9 mEq/L. Growth hormone secreting pathology was associated with lower postoperative nadir sodium, while higher preoperative sodium was associated with higher postoperative nadir sodium.
CONCLUSIONS CONCLUSIONS
Hyponatremia is a common postoperative complication of EER for pituitary lesions that can cause significant morbidity, increase readmissions, and lead to increased healthcare costs.

Identifiants

pubmed: 39032637
pii: S1878-8750(24)01235-X
doi: 10.1016/j.wneu.2024.07.095
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Auteurs

M Harrison Snyder (MH)

Department of Neurosurgery, Tufts Medical Center, Boston, MA 02111.

Rahul D Rodrigues (RD)

Department of Neurosurgery, Tufts Medical Center, Boston, MA 02111.

Jesus Mejia (J)

Department of Neurosurgery, Tufts Medical Center, Boston, MA 02111.

Vaish Sharma (V)

Department of Neurosurgery, Tufts Medical Center, Boston, MA 02111.

Matt Kanter (M)

Department of Neurosurgery, Tufts Medical Center, Boston, MA 02111.

Julian K Wu (JK)

Department of Neurosurgery, Tufts Medical Center, Boston, MA 02111.

James T Kryzanski (JT)

Department of Neurosurgery, Tufts Medical Center, Boston, MA 02111.

Ronald M Lechan (RM)

Hypothalamic and Pituitary Disease Center, Division of Endocrinology, Diabetes and Metabolism, Tufts Medical Center, Boston, MA 02111.

Carl B Heilman (CB)

Department of Neurosurgery, Tufts Medical Center, Boston, MA 02111.

Mina G Safain (MG)

Department of Neurosurgery, Tufts Medical Center, Boston, MA 02111. Electronic address: mina.safain@tuftsmedicine.org.

Classifications MeSH